- Money Masters
- Posts
- 4 Stocks to Buy and Hold
4 Stocks to Buy and Hold
Kenny
May 09, 2025
In partnership with
Gold hitting record highs
The price of gold keeps heating up. If the record-breaking year of 2024 wasn't enough, gold hit a major historic 2025 milestone by crossing the $3,000/ounce threshold!
Here are 3 Key Reasons:
Looming economic & political uncertainty
Increasing central bank demand
Rising National Debt - over $36 Trillion
So, could gold surge even higher?
According to a recent statement from Jeffrey Gundlach, famed American business man and investor… “Gold continues its bull market that we’ve been talking about for a couple of years, ever since it was down to $1,800.” He expects gold to reach $4,000/oz.
Is it time you learn more about precious metals?
Get all the answers in your free 2025 Gold & Silver Kit. Plus, if you request your free kit today, you could qualify for up to 10% Instant Match in Bonus Silver*.
*Offer valid on qualified orders of Goldco premium products only. Receive up to 10% in free silver based on purchase amount; cannot be combined with other offers. Additional terms apply—see your customer agreement or contact your representative for details.
THE MONEY IDEA💡
4 Stocks to Buy and Hold
Welcome, we are 27,769 Money Masters and counting!
In a market shaped by tariffs, cautious consumer trends, and lingering economic questions, long-term investors can still find value in companies with proven stability and attractive income. This week, we highlight five resilient names: U.S. Bancorp, Bristol-Myers Squibb, Constellation Brands, and PepsiCo. Each combines defensive strength, solid fundamentals, and favorable valuations. For deeper investing insights, see The Money Path.
Let’s dive in.
THE MONEY IDEA💡
4 Stocks to Buy and Hold
Industry: Financials / Regional Banks
Current Status: 22% undervalued; 4-star rating, medium uncertainty, 4.8% dividend yield
Operational Efficiency – Among the best-in-class for cost control, driving strong returns on equity.
Valuation Support – Trading at a meaningful discount, offering room for upside as the market stabilizes.
Dividend Strength – A 4.8% yield provides steady income for shareholders.
Moat Advantages – A strong deposit base and diversified fee income create a durable competitive edge.
Resilient Business Mix – Non-interest income, including corporate trust services, adds earnings stability.
Bottom Line: U.S. Bancorp is a standout regional bank offering value, income, and operational excellence in a sector that rewards patience.
Industry: Healthcare / Pharmaceuticals
Current Status: 23% undervalued; 4-star rating, medium uncertainty, 4.9% dividend yield
Pipeline Strength – A rich lineup of next-generation drugs supports long-term growth potential.
Undervalued – Shares trade well below fair value, despite a wide economic moat and strong fundamentals.
Reliable Payout – The nearly 5% dividend yield adds solid income potential.
Defensive Profile – Pharmaceuticals remain a safe harbor in slow economies, with steady demand for key treatments.
Attractive Valuation – Shares trade at just 8x 2025 projected earnings, reflecting cautious market sentiment.
Bottom Line: Bristol-Myers Squibb blends income, defensiveness, and pipeline upside—an appealing choice for patient long-term investors.
Industry: Consumer Staples / Alcoholic Beverages
Current Status: 32% undervalued; 5-star rating, medium uncertainty, 2.2% dividend yield
Beer Powerhouse – Corona and Modelo anchor a dominant U.S. imported beer business.
Valuation Reset – Shares have lagged but now offer meaningful upside from current levels.
Steady Buybacks – Regular share repurchases enhance shareholder value alongside dividends.
Tariff Resilience – Core beer business remains compliant with trade agreements, limiting exposure.
Brand Durability – Premium positioning and customer loyalty support long-term revenue streams.
Bottom Line: Constellation Brands offers a mix of brand strength and valuation appeal, making it a worthy contender for patient investors looking to tap into consumer staples.
Industry: Consumer Staples / Food & Beverage
Current Status: 21% undervalued; 4-star rating, low uncertainty, 4% dividend yield
Iconic Brands – PepsiCo’s wide-ranging portfolio offers global recognition and customer loyalty.
Dividend Pillar – A 4% yield, supported by decades of consistent payout growth.
Resilient Demand – Even amid soft U.S. snack sales, global demand remains strong, reinforcing stability.
Valuation Opportunity – Recent underperformance has pushed shares below fair value, creating a potential entry point.
Focused Execution – Management is actively addressing headwinds, positioning for long-term growth.
Bottom Line: PepsiCo offers defensive strength, global reach, and reliable dividends, making it a core holding for long-term stability seekers.
Serious about your money? See our guides on investing and building wealth.
CRYPTO CORNER📈
Margentum
Launched in December 2024, Margentum is a digital asset inspired by silver and created by the same team behind the Money Masters newsletter.
Designed to complement Bitcoin’s role as digital gold, it focuses on simplicity, long-term value, and accessibility in an evolving financial landscape.
NEWSLETTER CORNER🗞️
Subscribe To Our Friends!
QUOTE CORNER📄
Quote of The Week
You are now closer to money mastery!🎉
What did you think of this week’s newsletter?
Did you like it? How can we improve?
Hit reply and share some feedback!
How was this newsletter (honestly)? |
Learn AI in 5 minutes a day
What’s the secret to staying ahead of the curve in the world of AI? Information. Luckily, you can join 1,000,000+ early adopters reading The Rundown AI — the free newsletter that makes you smarter on AI with just a 5-minute read per day.
The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Reply